Rosetta Genomics Ltd
OTC:ROSGQ
Rosetta Genomics Ltd
OTC:ROSGQ
Price:
0.0001
USD
Market Closed
Market Cap:
$593
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Rosetta Genomics Ltd
OTC:ROSGQ
|
IL |
|
N
|
Namib Minerals
NASDAQ:NAMM
|
KY |
|
D
|
Danhua Chemical Technology Co Ltd
SSE:600844
|
CN |
|
Seoul Food Ind Co Ltd
KRX:004410
|
KR |
|
Panama Petrochem Ltd
NSE:PANAMAPET
|
IN |
|
MBL Infrastructures Ltd
NSE:MBLINFRA
|
IN |
|
G
|
Gander Gold Corp
CNSX:GAND
|
CA |
|
S
|
Starbucks Corp
HKEX:4337
|
US |
|
Hibino Corp
TSE:2469
|
JP |
|
H
|
Himacs Ltd
TSE:4299
|
JP |
|
C
|
Citaglobal Bhd
KLSE:CITAGLB
|
MY |
Income Statement
Earnings Waterfall
Rosetta Genomics Ltd
Rosetta Genomics Ltd
Income Statement
Rosetta Genomics Ltd
Rosetta Genomics Ltd
Currency: USD
| Sep-2006 | Dec-2006 | Dec-2007 | Sep-2008 | Dec-2008 | Sep-2009 | Dec-2009 | Sep-2010 | Dec-2010 | Sep-2014 | Dec-2014 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
0
N/A
|
0
N/A
|
0
+73%
|
0
+8%
|
0
-4%
|
1
+391%
|
3
+121%
|
8
+182%
|
9
+4%
|
9
+5%
|
9
-3%
|
9
+5%
|
5
-42%
|
6
+9%
|
|
| Gross Profit | ||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(2)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(5)
|
(5)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
(0)
N/A
|
(0)
-90%
|
0
N/A
|
(0)
N/A
|
(0)
+71%
|
0
N/A
|
1
+3 429%
|
2
+233%
|
3
+47%
|
3
-3%
|
3
+5%
|
2
-40%
|
1
-70%
|
1
+72%
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(6)
|
(8)
|
(11)
|
(7)
|
(15)
|
(7)
|
(15)
|
(8)
|
(15)
|
(3)
|
(14)
|
(8)
|
(18)
|
(16)
|
(19)
|
(17)
|
(17)
|
(15)
|
(14)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(5)
|
(3)
|
(6)
|
(3)
|
(8)
|
(4)
|
(8)
|
(3)
|
(12)
|
(7)
|
(15)
|
(11)
|
(14)
|
(14)
|
(14)
|
(12)
|
(11)
|
|
| Research & Development |
(4)
|
(5)
|
(6)
|
(4)
|
(9)
|
(4)
|
(7)
|
(3)
|
(6)
|
(0)
|
(2)
|
(1)
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(6)
N/A
|
(8)
-37%
|
(11)
-35%
|
(7)
+39%
|
(14)
-108%
|
(7)
+49%
|
(15)
-108%
|
(8)
+45%
|
(15)
-86%
|
(3)
+77%
|
(14)
-316%
|
(7)
+48%
|
(16)
-113%
|
(13)
+18%
|
(16)
-25%
|
(14)
+13%
|
(16)
-11%
|
(15)
+6%
|
(13)
+13%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
0
|
1
|
1
|
(5)
|
6
|
6
|
0
|
1
|
1
|
0
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(0)
|
1
|
1
|
|
| Non-Reccuring Items |
0
|
0
|
(5)
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
|
| Pre-Tax Income |
(6)
N/A
|
(8)
-30%
|
(15)
-93%
|
(11)
+23%
|
(9)
+16%
|
(1)
+85%
|
(15)
-946%
|
(7)
+53%
|
(15)
-110%
|
(3)
+77%
|
(15)
-332%
|
(8)
+45%
|
(17)
-119%
|
(15)
+15%
|
(18)
-22%
|
(18)
0%
|
(16)
+9%
|
(14)
+15%
|
(12)
+15%
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(6)
|
(8)
|
(15)
|
(11)
|
(9)
|
(1)
|
(15)
|
(7)
|
(15)
|
(3)
|
(15)
|
(8)
|
(17)
|
(15)
|
(18)
|
(18)
|
(16)
|
(14)
|
(12)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(6)
N/A
|
(8)
-30%
|
(15)
-93%
|
(11)
+24%
|
(9)
+16%
|
(2)
+75%
|
(17)
-609%
|
(7)
+59%
|
(15)
-118%
|
(3)
+77%
|
(15)
-332%
|
(8)
+45%
|
(17)
-119%
|
(15)
+15%
|
(18)
-23%
|
(18)
0%
|
(16)
+10%
|
(15)
+9%
|
(13)
+9%
|
|
| EPS (Diluted) |
-292.99
N/A
|
-2 146.59
-633%
|
-733
+66%
|
-560.5
+24%
|
-473
+16%
|
-116.5
+75%
|
-825.5
-609%
|
-339
+59%
|
-738
-118%
|
-3.5
+100%
|
-15.51
-343%
|
-6.43
+59%
|
-13.79
-114%
|
-8.54
+38%
|
-10.4
-22%
|
-10.42
0%
|
-9.31
+11%
|
-6.16
+34%
|
-5.25
+15%
|
|
Switch to:
Switch to:
See Also
Discover More
